Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01534130
Other study ID # 30801488
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2011
Est. completion date August 2012

Study information

Verified date February 2020
Source Chengdu University of Traditional Chinese Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will conduct acupuncture for participants with chronic fatigue syndrome(CFS). Firstly the investigators aim to figure out the characteristic of sleep structure of CFS and the changes caused by acupuncture. Secondly the investigators seek to investigate the characteristic of sleep-wake rhythm, slow wave sleep(SWS)-rapid eye movement(REM)sleep rhythm, and REM sleep rhythm of CFS and the readjusting of acupuncture for it. Thirdly the investigators want to know the efficacy of acupuncture for relieving the fatigue, reducing accompanying symptoms and for improving the life quality of CFS.


Description:

This trial is a randomized, placebo controlled clinical trial. 72 participants with CFS are randomly allocated to two different groups. Treatment group is acupuncture, while the control group is sham acupuncture. The ratio of treatment group and control group is 2:1. Both acupuncture and sham acupuncture group will receive 12 sessions of verum/sham acupuncture in 4 weeks.

The result of this trial (available in 2011) will supply evidence on the efficacy of acupuncture for sleep disorder of CFS.


Recruitment information / eligibility

Status Completed
Enrollment 72
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

1. Participants who meet the diagnosis criteria of CFS;

2. Clinically evaluated, exclude any disease that can explain the chronic fatigue;

3. The onset age of CFS is between 18 and 50 years old;

4. Have not taken any hypnotic, melatonin, or antidepressants within 45 days;

5. Willing to finish the whole observation period;

6. With written consent form signed by themselves.

Exclusion Criteria:

1. Chronic fatigue caused by diseases such as internal diseases(for example, pulmonary emphysema, rheumatoid arthritis, etc.), mental illness(for example, any type of dementia paranoids, depression, etc.), some diseases that just onset or evaluated (for example, sleep deprivation, untreated diabetes, etc.), some diseases that need recovery gradually(for example, restless legs syndrome, lactation, etc.), morbid obesity;

2. Participants in other clinical research;

3. Pregnant women, lactating women.

Study Design


Intervention

Device:
Acupuncture
Participants will receive five sessions of verum acupuncture in the first week after randomization, three sessions in the second and third weeks after randomization, and two sessions in the forth week after randomization.
Sham acupuncture
Participants will receive five sessions of sham acupuncture in the first week after randomization, three sessions in the second and third weeks after randomization, and two sessions in the forth week after randomization.

Locations

Country Name City State
China Chengdu university of Traditonal Chinese Medcine Chengdu Si Chuan Province

Sponsors (2)

Lead Sponsor Collaborator
Chengdu University of Traditional Chinese Medicine West China Hospital

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The sleep perception The percentage of the ratio between the total sleep time perceived by the patient and the total sleep time obtained by PSG. Change from baseline in sleep perception at 4 weeks
Secondary The Pittsburgh Sleep Quality Index(PSQI) Change from baseline in PSQI at 4 weeks
Secondary The Fatigue Severity Scale(FSS) Change from baseline in FSS at 4 weeks
Secondary The Somatic and Psychological Health Report(SPHR) Change from baseline in SPHR at 4 weeks
Secondary The Medical outcomes Study 36-Item Short-Form Health Survey questionnaire(SF-36) Change from baseline in SF-36 at 4 weeks
Secondary Sleep-wake rhythm Change from baseline in sleep-wake rhythm at 4 weeks
Secondary DSWS-REM sleep rhythm Change from baseline in DSWS-REM sleep rhythm at 4 weeks
Secondary REM sleep rhythm Change from baseline in REM sleep rhythm at 4 weeks
Secondary Sleep latency Change from baseline in sleep latency at 4 weeks
Secondary Total sleep time Change from baseline in total sleep time at 4 weeks
Secondary Sleep efficiency Change from baseline in sleep efficiency at 4 weeks
Secondary Percentage of every sleep stage Change from baseline in percentage of every sleep stage at 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05454683 - Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome N/A
Completed NCT01686074 - Motor Control in Chronic Fatigue Syndrome and Fibromyalgia N/A
Completed NCT02075489 - Acupressure for Pain Management and Fatigue Relief in Gulf War Veterans N/A
Completed NCT01651754 - Humoral and Cellular Immune Responses After Influenza Vaccination in Patients With Postcancer Fatigue and in Patients With Chronic Fatigue Syndrome N/A
Completed NCT00540254 - Behavioral Insomnia Therapy With Chronic Fatigue Syndrome Phase 1/Phase 2
Active, not recruiting NCT00071162 - Genetics of Fibromyalgia N/A
Withdrawn NCT04870476 - Feasibility and Acceptability of the Internet-delivered Treatment "One Step at the Time" for Bodily Distress Syndrome N/A
Completed NCT05730660 - Quercetin Phytosome® Chronic Fatigue Syndrome N/A
Recruiting NCT04542161 - Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Phase 2
Recruiting NCT03807973 - Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. Phase 1
Recruiting NCT05719493 - Effectiveness and Health Benefits of a Nutritional, Chronobiological and Physical Exercise Intervention in Fibromyalgia and Chronic Fatigue Syndrome (SYNCHRONIZE +) N/A
Recruiting NCT05967052 - Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation Phase 2
Terminated NCT01730495 - Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome Phase 2
Completed NCT01650636 - Patient-Partner Stress Management Effects on Chronic Fatigue Syndrome Symptoms and Neuroimmune Process N/A
Completed NCT01156909 - B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome Phase 2
Completed NCT01046370 - A Pilot Study of Amygdala Retraining Program in Patients With Chronic Fatigue Syndrome, Chronic Fatigue and Fibromyalgia N/A
Completed NCT00100412 - Hyporeactivity and Gulf War Illness N/A
Recruiting NCT06128967 - A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The REVIVE Trial Phase 3
Completed NCT02669212 - Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health N/A
Not yet recruiting NCT06011135 - Exploring Worry in CFS/ME